FinanceCity
HealthcareNSE · BSE

Laurus Labs Limited

LAURUSLABS · ISIN INE947Q01028

Share price

₹1,365 -1.74%

Market capitalisation

₹73744 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹73744 Cr

Current price

₹1,365

-1.74% today

52W high

₹1,457

52W low

₹641

Stock P/E

83.28

P/B ratio

13.91

02 · Per share & returns

EPS (TTM)

₹16.39

Book value

₹98.16

ROE

17.74%

ROA

8.18%

Dividend yield

0.17%

Beta

0.43

03 · Financials (TTM)

By the numbers

Revenue

₹6813 Cr

+5.30% YoY

EBITDA

₹1779 Cr

Net profit

₹889 Cr

+19.40% YoY

Profit margin

13.05%

Operating margin

21.62%

Total debt

₹2518 Cr

Total cash

₹114 Cr

Debt / equity

0.46x

Current ratio

1.33x

Payout ratio

9.73%

04 · Analyst view

Target price

₹1,055

Upside

-22.70%

Consensus

HOLD

Analysts

13

05 · Shareholding pattern

Who owns LAURUSLABS?

  • Promoters

    27.49%

    Founders & promoter group

  • Institutions

    30.89%

    FII + DII

  • Public

    41.62%

    Retail & non-institutional

As of 31 Mar 2026 · Source: NSE corporate filings

06 · Registration & listing

On the record

Symbol
LAURUSLABS
Exchange
NSE · BSE
CIN
ISIN
INE947Q01028
BSE code
540222
Sector
Healthcare
Industry
Healthcare
Face value
₹2
Listing date
18 Dec 2016
Employees
7,059
Headquarters
Hyderabad, India

07 · About

What is Laurus Labs Limited?

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

08 · Common questions

Frequently asked

What is the CIN of Laurus Labs Limited?+

The Corporate Identity Number for Laurus Labs Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Laurus Labs Limited?+

Promoter holding in LAURUSLABS is approximately 27.49%, as disclosed in the latest published shareholding pattern.

What is the market capitalisation of Laurus Labs Limited?+

Laurus Labs Limited (LAURUSLABS) has a market capitalisation of approximately ₹73744 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other healthcare listings

Full sector →